In message <[log in to unmask]>, Samuel
Vasikaran <[log in to unmask]> writes
>I have been following this as well as previous discussions relating
>to Guy's poison's unit. Having left UK seven years ago, I do not
>know what the staffing structure of the Unit is, but to my knowledge
>no one from the Unit has replied to or commented on the issues raised
>in this forum. Do they have Clinical Biochemists or ACB / RCPA
>members involved in running this Unit? Shouldn't ACB or RCPA
>approach the Unit formally to discuss policy with them?
A reply to some of the points made in previous discussions was posted. I
have attached it below for Dr Vasikaran and anyone else who missed it
first time round.
[ Section: 1/1 File: npis1_.rtf Encoder: Turnpike Version 3.01 ]
begin 644 npis1_.rtf
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M8FQU93`[7')E9#(U-5QG<F5E;C!<8FQU93(U-3M<<F5D,C4U7&=R965N,%QB
M;'5E,#M<<F5D,C4U7&=R965N,C4U7&)L=64P.UQR960R-35<9W)E96XR-35<
M8FQU93(U-3M<<F5D,%QG<F5E;C!<8FQU93$R.#M<<F5D,%QG<F5E;C$R.%QB
M;'5E,3(X.UQR960P7&=R965N,3(X7&)L=64P.UQR960Q,CA<9W)E96XP7&)L
M=64Q,C@[7')E9#$R.%QG<F5E;C!<8FQU93`[7')E9#$R.%QG<F5E;C$R.%QB
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M961O;C$P(&5N9&YO=&4@<F5F97)E;F-E.WU[7',Q-R`-"EQF,UQL86YG,C`U
M-R!<<V)A<V5D;VXP7'-N97AT,3<@9F]O=&YO=&4@=&5X=#M]>UPJ7&-S,3@@
M7&%D9&ET:79E7'-U<&5R(%QS8F%S961O;C$P(&9O;W1N;W1E(')E9F5R96YC
M93M]>UQS,3E<9FDM-S(P7&QI-S(P7')I-S(P7'-B-#@P7'1Q<EQT;&1O=%QT
M>#DS-C!<:'EP:'!A<C`@7&8S(%QS8F%S961O;C!<<VYE>'0P('1O8R`Q.WU[
M7',R,%QF:2TW,C!<;&DQ-#0P7')I-S(P7'1Q<EQT;&1O=%QT>#DS-C!<:'EP
M:'!A<C`@7&8S(`T*7'-B87-E9&]N,%QS;F5X=#`@=&]C(#([?7M<<S(Q7&9I
M+3<R,%QL:3(Q-C!<<FDW,C!<='%R7'1L9&]T7'1X.3,V,%QH>7!H<&%R,"!<
M9C,@7'-B87-E9&]N,%QS;F5X=#`@=&]C(#,[?7M<<S(R7&9I+3<R,%QL:3(X
M.#!<<FDW,C!<='%R7'1L9&]T7'1X.3,V,%QH>7!H<&%R,"!<9C,@7'-B87-E
M9&]N,%QS;F5X=#`@=&]C(#0[?7M<<S(S7&9I+3<R,%QL:3,V,#!<<FDW,C!<
M='%R7'1L9&]T7'1X.3,V,%QH>7!H<&%R,"!<9C,@#0I<<V)A<V5D;VXP7'-N
M97AT,"!T;V,@-3M]>UQS,C1<9FDM-S(P7&QI-S(P7'1Q<EQT>#DS-C!<:'EP
M:'!A<C`@7&8S(%QS8F%S961O;C!<<VYE>'0P('1O8R`V.WU[7',R-5QF:2TW
M,C!<;&DW,C!<:'EP:'!A<C`@7&8S(%QS8F%S961O;C!<<VYE>'0P('1O8R`W
M.WU[7',R-EQF:2TW,C!<;&DW,C!<='%R7'1X.3,V,%QH>7!H<&%R,"!<9C,@
M7'-B87-E9&]N,%QS;F5X=#`@=&]C(#@[?7L-"EQS,C=<9FDM-S(P7&QI-S(P
M7'1Q<EQT;&1O=%QT>#DS-C!<:'EP:'!A<C`@7&8S(%QS8F%S961O;C!<<VYE
M>'0P('1O8R`Y.WU[7',R.%QF:2TQ-#0P7&QI,30T,%QR:3<R,%QT<7)<=&QD
M;W1<='@Y,S8P7&AY<&AP87(P(%QF,R!<<V)A<V5D;VXP7'-N97AT,"!I;F1E
M>"`Q.WU[7',R.5QF:2TW,C!<;&DQ-#0P7')I-S(P7'1Q<EQT;&1O=%QT>#DS
M-C!<:'EP:'!A<C`@7&8S(%QS8F%S961O;C!<<VYE>'0P(&EN9&5X(#([?7L-
M"EQS,S!<='%R7'1X.3,V,%QH>7!H<&%R,"!<9C,@7'-B87-E9&]N,%QS;F5X
M=#`@=&]A(&AE861I;F<[?7M<<S,Q(%QF,UQL86YG,C`U-R!<<V)A<V5D;VXP
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M9VPQ-#0P7&UA<F=R,30T,"`-"EQF=&YB:EQA96YD9&]C7&AY<&AH;W1Z.3$V
M7&UA:V5B86-K=7!<869T;FYA<EQN;W1A8FEN9%QW<F%P=')S<%QN;V-O;&)A
M;%QT<F%N<VUF7&AY<&AC87!S,"!<9F5T,'M<*EQF=&YS97`@7'!A<F1<<&QA
M:6X@7&8S7&QA;F<R,#4W(%QC:&9T;G-E<"`-"EQP87(@?7M<*EQA9G1N<V5P
M(%QP87)D7'!L86EN(%QS;"TR,%QS;&UU;'0P(%QF,UQL86YG,C`U-R`-"EQP
M87(@?7M<*EQA9G1N<V5P8R!<<&%R9%QP;&%I;B!<9C-<;&%N9S(P-3<@(`T*
M7'!A<B!]>UPJ7&%F=&YC;B!<<&%R9%QP;&%I;B!<9C-<;&%N9S(P-3<@(`T*
M7'!A<B!]7'-E8W1D(%QP9VYR97-T87)T7&QI;F5X,%QH96%D97)Y,30T,%QF
M;V]T97)Y,30T,%QC;VQS>#<P.2![7"I<<&YS96-L=FPQ7'!N=6-R;5QP;G-T
M87)T,2![7'!N='AT82`N?7U[7"I<<&YS96-L=FPR7'!N=6-L=')<<&YS=&%R
M=#$@>UQP;G1X=&$@+GU]>UPJ7'!N<V5C;'9L,UQP;F1E8UQP;G-T87)T,2![
M7'!N='AT82`N?7U[7"I<<&YS96-L=FPT7'!N;&-L=')<<&YS=&%R=#$@>UQP
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M*7U]#0I<<&%R9%QP;&%I;B!<<6I<:'EP:'!A<C`@7&8S7&QA;F<R,#4W('M<
M9C5<97AP;F0P7&5X<&YD='<M,R!792!W<FET92!I;B!R97-P;VYS92!T;R!$
M;W5G($AI<G-T)W,@;F]T92!O;B!R97%U97-T<R!F;W(@86YA;'ES97,@<F5P
M;W)T961L>2!F;VQL;W=I;F<@861V:6-E(&9R;VT@=&AE($Y025,@86YD('-U
M8G-E<75E;G0@8V]M;65N=',N#0I<<&%R('U<<&%R9"!<<6I<:'EP:'!A<C`@
M>UQF-5QE>'!N9#!<97AP;F1T=RTS(`T*7'!A<B!]7'!A<F0@7'%J7&AY<&AP
M87(P('M<9C5<97AP;F0P7&5X<&YD='<M,R!4:&4@3E!)4R!C=7)R96YT;'D@
M9&5A;',@=VET:"!S;VUE(#(U,"PP,#`@8V%L;',@<&5R(&%N;G5M+B!4:&5R
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M:6UE<R`H8F5T=V5E;B!A8F]U="`R,"XP,"!A;F0@,#(N,#`I(&%N(&EN9F]R
M;6%T:6]N(&]F9FEC97(@870@=&AE($QO;F1O;B!C96YT<F4@=VEL;"!D96$-
M"FP@=VET:"`R,"!E;G%U:7)I97,@<&5R(&AO=7(N($1E=&%I;',@;V8@96%C
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M,R`-"EQP87(@?5QP87)D(%QQ:EQH>7!H<&%R,"![7&8U7&5X<&YD,%QE>'!N
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M(`T*=&AE;7-E;'9E<R!M:6=H="!B92!C;VYS:61E<F5D(&YE9VQI9V5N="X@
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M=F5R('1H92!Y96%R<R`H<V5E+"!F;W(@97AA;7!L92P@4VEM<&QE('1E<W1S
M('1O(&1E=&5C="!P;VES;VYI;F<N($H@0VQI;B!0871H;VP@,3DX.#LT,3HY
M.38M,3`P-"!A;F0@0F%S:6,@86YA;'ET:6-A;"!T;WAI8V]L;V=Y+B!72$\L
M($=E;F5V82P@,3DY-2DN#0I<<&%R('U<<&%R9"!<<6I<:'EP:'!A<C`@>UQF
M-5QE>'!N9#!<97AP;F1T=RTS(`T*7'!A<B!]7'!A<F0@7'%J7&AY<&AP87(P
M('M<9C5<97AP;F0P7&5X<&YD='<M,R!!<R!R96=A<F1S($1O=6<@2&ER<W1<
M<G%U;W1E(`T*<R!Q=65S=&EO;B!A8F]U="!U<F=E;G0@5#,@86YD(%0T(&%S
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M(&UA;F%G96UE;G0@;V8@82!V97)Y('-I8VL@<&%T:65N=`T*7'!A<B!]7'!A
M<F0@7'%J7&AY<&AP87(P('M<9C5<97AP;F0P7&5X<&YD='<M,R`-"EQP87(@
M?5QP87)D(%QQ:EQH>7!H<&%R,"![7&8U7&5X<&YD,%QE>'!N9'1W+3,@#0I4
M:&ES(&EL;'5S=')A=&5S(&]N92!P<F]B;&5M.B!H;W<@=&\@96YS=7)E('1H
M870@3E!)4R!A9'9I8V4@:7,@<F5C;W)D960@8V]R<F5C=&QY(&)Y('1H92!U
M<V5R(&%N9"!T:&%T(&%P<')O<')I871E(&%C=&EO;B!I<R!T86ME;BX@5&AE
M($Y025,@96UP:&%S:7,@:7,@=&\@=')Y('1O('-T;W`@<V5C;VYD+W1H:7)D
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M96QL+"!I;B`-"F%D9&ET:6]N('1O('!U8FQI8V%T:6]N<R]T97AT8F]O:W,L
M(&UA;GD@:&]S<&ET86QS(&EN(%-C;W1L86YD(&%N9"!.;W)T:&5R;B!)<F5L
M86YD("!A;F0@86)O=70@-3`@)2!I;B!%;F=L86YD(&AA=F4@86-C97-S('1O
M('1H92!.4$E3(%1/6$)!4T4@<WES=&5M('=H:6-H(&%L;&]W<R!O;BUL:6YE
M('9I97=I;F<@;V8@=&AE($Y025,@4&]I<V]N<R!);F9O<FUA=&EO;B!D871A
M8F%S92X-"EQP87(@?5QP87)D(%QQ:EQH>7!H<&%R,"![7&8U7&5X<&YD,%QE
M>'!N9'1W+3,@#0I<<&%R('U<<&%R9"!<<6I<:'EP:'!A<C`@>UQF-5QE>'!N
M9#!<97AP;F1T=RTS(`T*5$]80D%312!I<R!A;B!O;BUL:6YE(&1A=&%B87-E
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M<F0@7'%J7&AY<&AP87(P('M<9C5<97AP;F0P7&5X<&YD='<M,R`-"EQP87(@
M92UM86EL.B!S<&EB0&-O;7!U<V5R=F4N8V]M#0I<<&%R('!H;VYE.B`P,3,Q
M(#4S-B`R,CDX+S(S,#,-"EQP87(@<&]S=#H@4V-O='1I<V@@4&]I<V]N<R!)
M;F9O<FUA=&EO;B!"=7)E874L(%1H92!2;WEA;"!);F9I<FUA<GDL($5D:6YB
M=7)G:"!%2#,@.5E7#0I<<&%R(`T*7'!A<B!]7'!A<F0@7'%J7&AY<&AP87(P
M('M<9C5<97AP;F0P7&5X<&YD='<M,R`-"E1H92!S96-O;F0@<')O8FQE;2!I
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M86P@=F%L=64@;PT*9B!T:&5S92!A<W-A>7,L(&)U="!T:&4@861V:6-E(`T*
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M:'!A<C`@>UQF-5QE>'!N9#!<97AP;F1T=RTS(`T*7'!A<B!]7'!A<F0@7'%J
M7&AY<&AP87(P('M<9C5<97AP;F0P7&5X<&YD='<M,R`-"E1/6$)!4T4@:6YC
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M<6I<:'EP:'!A<C`@>UQF-5QE>'!N9#!<97AP;F1T=RTS(`T*7'!A<B!]7'!A
M<F0@7'%J7&AY<&AP87(P('M<9C5<97AP;F0P7&5X<&YD='<M,R`-"D9I;F%L
M;'DL(&-O;&QE86=U97,@;6EG:'0@;&EK92!T;R!K;F]W('1H870@=&AE<F4@
M:7,@8W5R<F5N=&QY(&$@<F5S=')U8W1U<FEN9R!O9B!T:&4@3E!)4R!A8W)O
M<W,@=&AE(%5+('=I=&@@82!N97<@;6%N86=E;65N="!B;V%R9"!W:&EC:"!I
M;F-L=61E<R!!*T4@8V]N<W5L=&%N=',L(&$@<&%E9&EA=')I8VEA;BP@86YD
M(&$@1U`@:6X@861D:71I;VX@=&\@=&AE($Y025,@9&ER96-T;W)S+B!)="!M
M:6=H="!B92!S96YS:6)L92!T;R!H879E(`T*82!C;&EN:6-A;"!C:&5M:7-T
M(&]R(&]T:&5R(&QA8BUA=V%R92!P97)S;VX@;VX@=&AE(&)O87)D(&%S('=E
M;&PN(%=E('=O=6QD(&)E(&=R871E9G5L(&9O<B!Y;W5R(&-O;6UE;G1S+B!)
M="!W;W5L9"!A;'-O(&)E(&AE;'!F=6P@:68@8V]L;&5A9W5E<R!W;W5L9"!S
M96YD('5S("A";V)`;65D=&]X+F1E;6]N+F-O+G5K*2!D971A:6QS(&]F('!R
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M;F%T960N#0I<<&%R('U<<&%R9"!<<6I<:'EP:'!A<C`@>UQF-5QE>'!N9#!<
M97AP;F1T=RTS(`T*7'!A<B!';'EN(%9O;&%N<RP@1&ER96-T;W(-"EQP87(@
M3FEC:R!%9'=A<F1S+"!-86YA9V5R($Y025,@*$QO;F1O;BD-"EQP87(@0F]B
I($9L86YA9V%N+"!#;VYS=6QT86YT($)I;V-H96UI<W0-"EQP87(@?7T`
`
end
sum -r/size 55779/12795 section (from "begin" to "end")
sum -r/size 3612/9266 entire input file
As regards the current situation, Toxbase will be available on-line from
16 August. Please contact Alison Good ([log in to unmask]) for access
details. In time there will be web pages and a comments/criticisms box
as well. Perhaps more appropriate to discuss specific
issues/questions/patients there (or ring/write to one of the centres)
than by publishing presumably confidential patient information on the
mailbase? There will also soon be one NPIS phone number with calls being
routed to an appropriate centre by area/call load.
As regards the question of clinical chemistry input to the NPIS via
membership of the NPIS Board, this was mooted but not thought necessary
- an attempt to limit the size of the board I think. But any specific
points can be forwarded to me to pass on, posted on the NPIS box when it
gets going, etc. The whole aim of the restructuring exercise which is
being undertaken is to make best use of available resources to deliver
the most cost effective, appropriate service to everyone, clinical
chemists included.
--
Bob.Flanagan
Medical Toxicology Unit
Avonley Road
London SE14 5ER
Tel: +44 171 771 5365
Fax: +44 171 771 5363
e-mail: [log in to unmask]
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
|
